title: Understanding EMPA-REG OUTCOME.
authors.affiliation: Diabetes Center, Department of Internal Medicine, VU University Medical Center, 1081 HV Amsterdam, Netherlands. Electronic address: ma.muskiet@vumc.nl.
authors.forename: Marcel H A
authors.initials: MH
authors.lastname: Muskiet
authors.affiliation: Diabetes Center, Department of Internal Medicine, VU University Medical Center, 1081 HV Amsterdam, Netherlands.
authors.forename: Daniël H
authors.initials: DH
authors.lastname: van Raalte
authors.forename: Erik J M
authors.initials: EJ
authors.lastname: van Bommel
authors.affiliation: Diabetes Center, Department of Internal Medicine, VU University Medical Center, 1081 HV Amsterdam, Netherlands.
authors.forename: Erik
authors.initials: E
authors.lastname: van Bommel
authors.affiliation: Diabetes Center, Department of Internal Medicine, VU University Medical Center, 1081 HV Amsterdam, Netherlands.
authors.forename: Mark M
authors.initials: MM
authors.lastname: Smits
authors.affiliation: Diabetes Center, Department of Internal Medicine, VU University Medical Center, 1081 HV Amsterdam, Netherlands.
authors.forename: Lennart
authors.initials: L
authors.lastname: Tonneijck
mesh_terms: D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D005960:Glucosides / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male
chemical_list: D001559:Benzhydryl Compounds; D005960:Glucosides; D007004:Hypoglycemic Agents